JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P 500 Value ETF
IVE
|
+$2.05B |
| 2 |
iShares S&P 500 Growth ETF
IVW
|
+$1.92B |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.13B |
| 4 |
iShares Russell 1000 Value ETF
IWD
|
+$1.1B |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$1.06B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.24B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.12B |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$989M |
| 4 |
Microsoft
MSFT
|
+$973M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$931M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.54% |
| 2 | Technology | 14.97% |
| 3 | Healthcare | 10.91% |
| 4 | Financials | 10.87% |
| 5 | Consumer Discretionary | 8.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
NWHM
4551
DELISTED
THE NEW HOME COMPANY INC.
NWHM
| $49K | ﹤0.01% |
35,854
-5,765
| -14% | -$25K |
2017 Q4
9 quarters
|
|
|
KIN
4552
DELISTED
Kindred Biosciences, Inc.
KIN
| $49K | ﹤0.01% |
12,180
+36
| +0.3% | +$306 |
2017 Q2
11 quarters
|
|
4553
iShares Core Moderate Allocation ETF
AOM
$1.87B
| $48K | ﹤0.01% |
1,315
| – | – |
2016 Q2
15 quarters
|
|
4554
WisdomTree International SmallCap Dividend Fund
DLS
$1.04B
| $48K | ﹤0.01% |
1,008
+866
| +610% | +$54K |
2013 Q2
27 quarters
|
|
4555
Funko
FNKO
$328M
| $48K | ﹤0.01% |
11,876
-424
| -3% | -$4.32K |
2017 Q4
9 quarters
|
|
4556
Invesco Dorsey Wright Developed Markets Momentum ETF
PIZ
$650M
| $48K | ﹤0.01% |
2,098
-1,917
| -48% | -$51.9K |
2013 Q2
27 quarters
|
|
4557
Global X Silver Miners ETF NEW
SIL
$4.43B
| $48K | ﹤0.01% |
2,030
-4,870
| -71% | -$141K |
2018 Q2
7 quarters
|
|
4558
Invesco Municipal Opportunity Trust
VMO
$574M
| $48K | ﹤0.01% |
4,160
-537
| -11% | -$6.63K |
2015 Q4
17 quarters
|
|
|
LL
4559
DELISTED
LL Flooring Holdings, Inc.
LL
| $48K | ﹤0.01% |
10,106
+755
| +8% | +$5.91K |
2015 Q4
17 quarters
|
|
|
SDRL
4560
DELISTED
Seadrill Limited Common Stock
SDRL
| $48K | ﹤0.01% |
111,185
+72,837
| +190% | +$90.5K |
2013 Q2
27 quarters
|
|
4561
Bank7 Corp
BSVN
$528M
| $47K | ﹤0.01% |
6,029
+1,255
| +26% | +$19.4K |
2018 Q4
5 quarters
|
|
4562
Ceco Environmental
CECO
$4.31B
| $47K | ﹤0.01% |
10,164
+30
| +0.3% | +$204 |
2016 Q4
13 quarters
|
|
4563
Schwab Short-Term US Treasury ETF
SCHO
$15.3B
| $47K | ﹤0.01% |
1,820
+662
| +57% | +$16.9K |
2019 Q4
1 quarter
|
|
4564
Vanguard US Value Factor ETF
VFVA
$902M
| $47K | ﹤0.01% |
+1,000
| New | +$66.8K |
2020 Q1
0 quarters
|
|
|
CSCI
4565
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
| $47K | ﹤0.01% |
911
-11
| -1% | -$1K |
2017 Q2
11 quarters
|
|
4566
CrossAmerica Partners
CAPL
$831M
| $46K | ﹤0.01% |
+5,714
| New | +$93.4K |
2020 Q1
0 quarters
|
|
4567
Global X Internet of Things ETF
SNSR
$221M
| $46K | ﹤0.01% |
+2,536
| New | +$55.5K |
2020 Q1
0 quarters
|
|
4568
XBiotech
XBIT
$66.8M
| $46K | ﹤0.01% |
4,277
-1,980
| -32% | -$32.2K |
2019 Q2
3 quarters
|
|
|
VBIV
4569
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $46K | ﹤0.01% |
1,635
-5,045
| -76% | -$196K |
2019 Q2
3 quarters
|
|
|
FSTX
4570
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| $46K | ﹤0.01% |
12,373
+8,118
| +191% | +$42K |
2018 Q2
7 quarters
|
|
4571
WisdomTree US SmallCap Earnings Fund
EES
$689M
| $45K | ﹤0.01% |
2,015
+515
| +34% | +$16.6K |
2018 Q4
5 quarters
|
|
4572
Immunovant
IMVT
$6.94B
| $45K | ﹤0.01% |
+2,908
| New | +$43.7K |
2020 Q1
0 quarters
|
|
4573
The Joint Corp
JYNT
$103M
| $45K | ﹤0.01% |
4,172
-109
| -3% | -$1.6K |
2019 Q1
4 quarters
|
|
4574
iShares AAA-A Rated Corporate Bond ETF
QLTA
$1.14B
| $45K | ﹤0.01% |
823
| – | – |
2016 Q3
14 quarters
|
|
4575
Travelzoo
TZOO
$53.2M
| $45K | ﹤0.01% |
11,217
-26,940
| -71% | -$237K |
2016 Q2
15 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2020 Portfolio in Review
As of Q1 2020, JP Morgan Chase held 6,012 positions worth $426B, down 21% from $536B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase deployed $14B of net new capital in Q1 2020, opening 362 new positions and adding to 2,382 existing holdings. Its largest new stake was NextEra Energy, Inc. 5.279% Corporate Units: 1,245,017 shares worth $54.9M.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was JPMorgan BetaBuilders Japan ETF, an estimated $1.24B trimmed.
- JP Morgan Chase's largest Q1 2020 buy was NextEra Energy, Inc. 5.279% Corporate Units: 1,245,017 shares worth $54.9M.
- JP Morgan Chase added most to iShares S&P 500 Value ETF in Q1 2020, an estimated $2.05B increase.
- JP Morgan Chase's biggest Q1 2020 reduction was JPMorgan BetaBuilders Japan ETF, cutting an estimated $1.24B.
- JP Morgan Chase fully exited Liberty Property Trust in Q1 2020, selling an estimated $264M.
- JP Morgan Chase's ten largest holdings make up 18% of its $426B portfolio in Q1 2020.
- JP Morgan Chase opened 362 new positions and closed 692 in Q1 2020.
- JP Morgan Chase's portfolio value fell 21% quarter-over-quarter to $426B.
Based on JP Morgan Chase's 13F filing for Q1 2020, filed 12 May 2020.